Irreversible Electroporation for the Ablation of Renal Cell Carcinoma: A Prospective, Human, In Vivo Study Protocol (IDEAL Phase 2b).
Mara BuijsKrijn P van LiendenPeter Gk WagstaffMatthijs Jv ScheltemaDaniel Martijn de BruinPatricia J ZondervanOtto M van DeldenTon G van LeeuwenJean J M C H de la RosetteMaria Pilar Laguna PesPublished in: JMIR research protocols (2017)
Clinicaltrials.gov registration number NCT02828709; https://clinicaltrials.gov/ct2/show/NCT02828709 (archived by WebCite at http://www.webcitation.org/6nmWK7Uu9). Dutch Central Committee on Research Involving Human Subjects NL56935.018.16.